Neuraminidase receptor binding variants of human influenza A(H3N2) viruses resulting from substitution of aspartic acid 151 in the catalytic site: a role in virus attachment?
about
Crystal structures of two subtype N10 neuraminidase-like proteins from bat influenza A viruses reveal a diverged putative active siteInfluenza Virus Neuraminidases with Reduced Enzymatic Activity That Avidly Bind Sialic Acid ReceptorsEvolution of the receptor binding properties of the influenza A(H3N2) hemagglutininComparison of mutation patterns in full-genome A/H3N2 influenza sequences obtained directly from clinical samples and the same samples after a single MDCK passageOutbreak of H3N2 influenza at a US military base in Djibouti during the H1N1 pandemic of 2009.Antiviral drug profile of human influenza A & B viruses circulating in India: 2004-2011.Influenza viruses with receptor-binding N1 neuraminidases occur sporadically in several lineages and show no attenuation in cell culture or mice.Haemagglutinin mutations and glycosylation changes shaped the 2012/13 influenza A(H3N2) epidemic, Houston, Texas.Influenza virus surveillance in Argentina during the 2012 season: antigenic characterization, genetic analysis and antiviral susceptibility.Improving the selection and development of influenza vaccine viruses - Report of a WHO informal consultation on improving influenza vaccine virus selection, Hong Kong SAR, China, 18-20 November 2015Role of Neuraminidase in Influenza A(H7N9) Virus Receptor BindingNeuraminidase inhibitor susceptibility testing in human influenza viruses: a laboratory surveillance perspective.The 2008-2009 H1N1 influenza virus exhibits reduced susceptibility to antibody inhibition: Implications for the prevalence of oseltamivir resistant variant viruses.Comparison of temporal and spatial dynamics of seasonal H3N2, pandemic H1N1 and highly pathogenic avian influenza H5N1 virus infections in ferretsAntigenic drift of the pandemic 2009 A(H1N1) influenza virus in A ferret model.Effects of egg-adaptation on receptor-binding and antigenic properties of recent influenza A (H3N2) vaccine viruses.The characteristics and antigenic properties of recently emerged subclade 3C.3a and 3C.2a human influenza A(H3N2) viruses passaged in MDCK cells.Integrating influenza antigenic dynamics with molecular evolutionSerologic assays for influenza surveillance, diagnosis and vaccine evaluation.Computational prediction of vaccine strains for human influenza A (H3N2) viruses.Recent H3N2 influenza virus clinical isolates rapidly acquire hemagglutinin or neuraminidase mutations when propagated for antigenic analysesWHO recommendations for the viruses to be used in the 2012 Southern Hemisphere Influenza Vaccine: epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from February to September 201Development of a neutralization assay for influenza virus using an endpoint assessment based on quantitative reverse-transcription PCRHuman H3N2 Influenza Viruses Isolated from 1968 To 2012 Show Varying Preference for Receptor Substructures with No Apparent Consequences for Disease or SpreadApplication of a seven-target pyrosequencing assay to improve the detection of neuraminidase inhibitor-resistant Influenza A(H3N2) virusesChallenges in antigenic characterization of circulating influenza A(H3N2) viruses during the 2011-2012 influenza season: an ongoing problem?Identification of Low- and High-Impact Hemagglutinin Amino Acid Substitutions That Drive Antigenic Drift of Influenza A(H1N1) Viruses.Optimization of a micro-neutralisation assay and its application in antigenic characterisation of influenza viruses.Frequency of influenza H3N2 intra-subtype reassortment: attributes and implications of reassortant spread.Phylogenetic relationships of the HA and NA genes between vaccine and seasonal influenza A(H3N2) strains in KoreaThe Interaction between Respiratory Pathogens and Mucus.Full Genome Characterization of Human Influenza A/H3N2 Isolates from Asian Countries Reveals a Rare Amantadine Resistance-Conferring Mutation and Novel PB1-F2 Polymorphisms.Cooperation between distinct viral variants promotes growth of H3N2 influenza in cell culture.Antigenic characterization of influenza viruses produced using synthetic DNA and novel backbones.Bioluminescence-based neuraminidase inhibition assay for monitoring influenza virus drug susceptibility in clinical specimens.Neutralizing Antibody Responses to Antigenically Drifted Influenza A(H3N2) Viruses among Children and Adolescents following 2014-2015 Inactivated and Live Attenuated Influenza Vaccination.Cell culture-selected substitutions in influenza A(H3N2) neuraminidase affect drug susceptibility assessment.A mutant influenza virus that uses an N1 neuraminidase as the receptor-binding protein.Optimization of a Quantitative Micro-neutralization Assay.A Pyrosequencing-Based Approach to High-Throughput Identification of Influenza A(H3N2) Virus Clades Harboring Antigenic Drift Variants.
P2860
Q27673677-6454CE8A-04B8-44D9-A57E-6EC5903D22A1Q27673691-D4BDC62E-250D-479F-AC2F-0544529896DBQ27675474-A7D01794-FBF9-437D-93D3-1F5448837901Q28534776-B76F4617-2A25-42FE-AA85-017DBB1742E9Q30356870-4F58C99A-3D2B-4F56-A982-A8D9AC672DEDQ30367631-7C5E1BCA-BBE6-4621-9A25-82D7E368ABD4Q30370985-17C1FA5D-F237-43E1-9C06-5CC5AADCBB7AQ30374828-7EF4F21E-F2B5-46CF-B021-8890440767B4Q30378860-30699A1E-FEB1-4BC7-8B61-A0B6A160F722Q30398002-71D29E60-7B9F-44A9-AAA1-675B43E05CEEQ30400467-904D64E4-DFF8-4932-9C3F-E7D32D52C321Q30408105-62E3105E-525B-4DDF-AD1A-9F74C66826D4Q30410229-83622E17-F6DB-4DF7-B120-74E2110DA83CQ30420448-20076FA7-30E2-41F2-944B-8B1ABF1B25DFQ30430458-F5BB91CF-7873-4DCE-9F9A-760AD155B657Q33573489-A2077F8D-6BF9-4AF3-92A3-AF1FC4B731F8Q33619857-FC6F0AB2-30E6-4DB4-B2AB-9271E5317D3EQ34039764-4F5E04C5-E31B-4861-AAB2-781264BF5745Q34194336-F289C5C6-21A9-42AD-8ECA-FE72F1FB2223Q34261553-29A3A8A4-5B78-4D3F-86F2-3AD43438BA34Q34262280-4B569004-7EA8-4CBF-B174-DA7C4732708DQ34295635-1F1ECAA8-BD09-46CF-AFAA-18A844E10E4EQ34598349-520A4D72-ADA1-4506-A1C1-99544202D497Q34785319-23CE9565-B4B4-4581-821F-0F9AD3C2304AQ35168895-49E1321B-33DE-4B42-A65D-82DEA58094A5Q35455493-5B9DD267-3289-4309-AE46-D44DBA624715Q35983371-D3952487-2D68-4C59-B2AE-E9DCA1DF8F38Q36161033-524506AF-D525-4A75-A198-2D2D4098C24BQ36235941-542C7A08-1623-4346-A82E-11FA12176669Q36296560-0243AB9D-9E63-4F0F-BE3B-D53E545CEAB3Q36577624-7A60619F-5E93-4EBD-888D-9DD6FD225FC2Q36656494-844CA153-A4D8-428B-AEEF-F147716E7432Q36723410-671DCCA8-34C1-4B46-B058-1F9DA0B1132FQ37083396-9D287D17-21F6-4942-B0EE-CA9CA4BE2209Q37263328-3B90222A-684A-4DEB-BAE3-78A51BFE2012Q37311543-6A04F236-1E19-4453-B2BC-4592466BCC22Q37335679-EBE1E05E-30D8-4996-B8B0-BBFB4F6B6E00Q37336357-10DB7507-0CB2-4098-A66C-DAF26BEA2795Q37580084-9D9C10D7-3462-4E60-8C1B-B210B2193B1CQ37581851-FF9AD969-C707-4490-B18E-2D8C5214D6AE
P2860
Neuraminidase receptor binding variants of human influenza A(H3N2) viruses resulting from substitution of aspartic acid 151 in the catalytic site: a role in virus attachment?
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Neuraminidase receptor binding ...... e: a role in virus attachment?
@ast
Neuraminidase receptor binding ...... e: a role in virus attachment?
@en
type
label
Neuraminidase receptor binding ...... e: a role in virus attachment?
@ast
Neuraminidase receptor binding ...... e: a role in virus attachment?
@en
prefLabel
Neuraminidase receptor binding ...... e: a role in virus attachment?
@ast
Neuraminidase receptor binding ...... e: a role in virus attachment?
@en
P2093
P2860
P356
P1433
P1476
Neuraminidase receptor binding ...... e: a role in virus attachment?
@en
P2093
Angie Lackenby
Johannes Kloess
Nicholas Cattle
Patrick Collins
Rodney Daniels
Stephen Wharton
Victoria Gregory
P2860
P304
P356
10.1128/JVI.00458-10
P407
P577
2010-04-21T00:00:00Z